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Background: Super-obesity is associated with significantly elevated rates of obstetric complications, adverse
perinatal outcomes and interventions. The purpose of this study was to determine the prevalence, risk factors,
management and perinatal outcomes of super-obese women giving birth in Australia.
Methods: A national population-based cohort study. Super-obese pregnant women (body mass index
(BMI) >50 kg/m2 or weight >140 kg) who gave birth between January 1 and October 31, 2010 and a comparison
cohort were identified using the Australasian Maternity Outcomes Surveillance System (AMOSS). Outcomes included
maternal and perinatal morbidity and mortality. Prevalence estimates calculated with 95 % confidence intervals
(CIs). Adjusted odds ratios (ORs) were calculated using multivariable logistic regression.
Results: 370 super-obese women with a median BMI of 52.8 kg/m2 (range 40.9–79.9 kg/m2) and prevalence of 2.1
per 1 000 women giving birth (95 % CI: 1.96–2.40). Super-obese women were significantly more likely to be public
patients (96.2 %), smoke (23.8 %) and be socio-economically disadvantaged (36.2 %). Compared with other women,
super-obese women had a significantly higher risk for obstetric (adjusted odds ratio (AOR) 2.42, 95 % CI: 1.77–3.29)
and medical (AOR: 2.89, 95 % CI: 2.64–4.11) complications during pregnancy, birth by caesarean section (51.6 %)
and admission to special care (HDU/ICU) (6.2 %). The 372 babies born to 365 super-obese women with outcomes
known had significantly higher rates of birthweight ≥4500 g (AOR 19.94, 95 % CI: 6.81–58.36), hospital transfer (AOR
3.81, 95 % CI: 1.93–7.55) and admission to Neonatal Intensive Care Unit (NICU) (AOR 1.83, 95 % CI: 1.27–2.65)
compared to babies of the comparison group, but not prematurity (10.5 % versus 9.2 %) or perinatal mortality (11.0
(95 % CI: 4.3–28.0) versus 6.6 (95 % CI: 2.6- 16.8) per 1 000 singleton births).
Conclusions: Super-obesity in pregnancy in Australia is associated with increased rates of pregnancy and birth
complications, and with social disadvantage. There is an urgent need to further address risk factors leading to
super-obesity among pregnant women and for maternity services to better address pre-pregnancy and pregnancy
care to reduce associated inequalities in perinatal outcomes.
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The prevalence of obesity (body mass index (BMI) ≥
30 kg/m2) among women of reproductive age continues
to rise in developed countries, with Australia at 28.3 %
among the highest in the world ahead of United Kingdom
[1] and similar to the United States. It is estimated that
about one in five women giving birth in Australia are
obese [2]. Of increasing concern is the rising rate of so-
called super-obesity, defined as a BMI of ≥ 50 kg/m2 in
pregnancy, or women weighing 225 % of ideal body weight
[3, 4]. Super-obesity is associated with significantly ele-
vated rates of obstetric complications, adverse perinatal
outcomes and interventions including pre-eclampsia, ges-
tational diabetes mellitus (GDM), preterm birth, caesarean
section, general anaesthesia, wound infection, intensive
care admission, macrosomia, neonatal hypoglycaemia and
congenital anomalies [3–6]. However, there has been no
national study of super-obesity in Australian women giv-
ing birth. A population study from the United Kingdom
reported the prevalence of women with BMI ≥50 kg/m2
as 8.7 per 10 000 women giving birth or 0.1 % [7]. In
contrast, the prevalence of super-obesity ranged from
1.8 % [4] in a 7-year (2000 to 2006) US retrospective co-
hort study in Missouri, to 2.2 % for a 12-year (1996 to
2007) case series of 19 700 women giving birth in South
Carolina [5]. A retrospective 12-year cohort study of 75
432 women giving birth in a Brisbane hospital (Australia)
found a significant increase in the proportion of Class III
obesity (≥40 kg/m2) during the course of the study [8].
This suggests that the prevalence of super-obesity among
women giving birth is also on the rise in Australia al-
though this has not been previously reported [8].
The objective of this study was to determine the preva-
lence, risk factors, management and perinatal outcomes of
super-obese women giving birth in Australia; and to deter-
mine the effect of maternal super-obesity on perinatal
outcomes compared with other women. We hypothesized
that pregnancy in super-obese women compared with
other women is associated with a higher risk of maternal
morbidity and adverse perinatal outcomes.
Methods
Study design and population
A national, prospective cohort study was undertaken
using the Australasian Maternity Outcomes Surveillance
System (AMOSS). The AMOSS methods have been de-
scribed in detail elsewhere [9]. Women were identified
by participating AMOSS sites, responding to a monthly
email that included negative reporting of whether a case
had been identified between January and October 2010.
Hospital (n = 226) sites progressively joined AMOSS on
completion of relevant ethics/governance processes and
were included for the period they participated in the
study. The denominator of 171 289 women giving birthwas calculated using the number of days of participation
in the study multiplied by number of births per day for
that hospital and gave approximate coverage of 66 % of
all women giving birth in Australia. The case definition
included any pregnant woman of 20 weeks’ gestation or
more who, at any point in pregnancy, had a BMI of
greater than 50 kg/m2 or a weight of more than 140 kg.
The case definition was clinician informed with a weight
of >140 kg at any point in pregnancy considered super-
obese irrespective of having a BMI <50 kg/m2. The com-
parison group for a series of AMOSS studies were the two
women who gave birth immediately before women with
placenta accreta and/or women who underwent a peripar-
tum hysterectomy between January 2010 and December
2011 [10]. The comparison group represented the general
population of women giving birth in Australia and New
Zealand and inclusion criteria did not include BMI, how-
ever all comparison women had a BMI ≤50 kg/m2 or
weight ≤140 kg.
A questionnaire completed by AMOSS site coordina-
tors for all eligible women sought information on demo-
graphic and pregnancy factors, obstetric interventions
and perinatal outcomes as well as models of antenatal
care, specified medical and obstetric complications and
bariatric equipment (e.g., high-weight capacity bed, oper-
ating table, hoist, chair) availability. Free-text responses
to questions regarding medical/obstetric morbidity were
categorised according to ICD-10 AM codes.
We anticipated identifying 264 super-obese women
and 528 comparison women over 12 months, based on
the prevalence of the United Kingdom study of 8.7 per
10 000 women giving birth [7]. These numbers give a
power of 80 % at the 5 % level of significance to detect
difference in proportions of outcomes (gestational dia-
betes, caesarean section and admission to NICU) by 10 %
in study group over a range of incidences from 5 to 30 %
in the comparison group.
Other study factors
The woman’s age was calculated in completed years at
the time of the antenatal care booking visit and classified
into four categories: <25, 25–29, 30–34, and ≥ 35 years.
Other demographic characteristics such as parity (0, 1–2,
and ≥ 3), Indigenous status, marital status, admission as
private/public patient, smoking during pregnancy, socio-
economic status (Australian socio-economic indices for
areas (SEIFA) of relative advantage/disadvantage quintile)
[11], previous caesarean section, multiple pregnancy and
assisted reproductive technology treatment were recorded.
Outcomes
Models of care, obstetric interventions, and birth out-
comes were measured for both groups. Health profes-
sional involvement during antenatal care, specific medical
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ability were recorded for the super-obese women only.
Statistical analysis
Prevalence estimates with 95 % confidence intervals
(CIs) were calculated. Distribution of BMI was graphic-
ally compared between super-obese women and the
comparison group. Chi-square or Fisher’s exact test was
used to investigate difference in obstetric interventions
and birth outcomes of study and comparison groups.
Multivariable logistic regression was used to examine
the medical and obstetric complications (gestational dia-
betes, gestational hypertension, pre-eclampsia, etc.),
labour characteristics (onset of labour and method of de-
livery), maternal outcomes (admission to ICU or HDU)
and perinatal outcomes (birthweight ≥4 500 g, admission
to NICU, and need for transfer). Odds ratio (OR) and
adjusted odds ratio (AOR) and 95 % confidence interval
(CI) were calculated. Adjustment was made for maternal
age, maternal Indigenous status, marital status, admis-
sion as private/public patient, smoking status, assisted
reproductive technology, parity, multiple gestation and
socio-economic status. Any p-values less than 0.05 were
considered statistically significant. Data were analysed
using the Statistical Package for the Social Sciences
software, version 22.0 (IBM Corporation, Somers, NY,
USA).Fig. 1 Surveillance and confirmed cases of super-obese women who gaveEthics approval
Ethics approval for AMOSS was granted by NSW Popu-
lation and Health Services Research Ethics Committee
and multiple Human Research Ethics Committees across
Australia [12] and the multiregional ethics approval in
New Zealand. The AMOSS studies are considered low-
risk under (Australian) National Health and Medical
Research Council (NHMRC) guidelines. The data col-
lected from case notes by onsite AMOSS data coordina-
tors were de-identified, and no consent was required by
participants. Data were reported at an aggregate level
only [12].
Results
A total of 370 super-obese pregnant women (297 women
had a BMI of greater than 50 kg/m2 and 73 women had
a weight of more than 140 kg) were confirmed as cases
with an estimated prevalence of 2.14 per 1000 (95 % CI:
1.96–2.40) women giving birth (Fig. 1). Data were
available for 621 women in the comparative group.
The median BMI (Fig. 2) of the super-obese women
was 52.8 kg/m2 (range, 40.9–79.9 kg/m2) compared to
24.8 kg/m2 (range, 16.3–48.9 kg/m2) for comparison
women. The median weight of super-obese women was
156 kg (range 108–204 kg) which was over twice the
median weight for the comparison women of 67 kg
(range 42–138 kg). Demographic and pregnancy-relatedbirth in Australia, 2010
Fig. 2 Distribution of body mass index of super-obese and comparison women who gave birth in Australia, 2010
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shown in Table 1. The super-obese women (cases) were of
similar age but of significantly higher parity than the com-
parison women (parity ≥ 3: 22.2 % versus 9.2 %, p < 0.01).
They were more likely to smoke (23.8 % versus 16.1 %,
p < 0.01), to be socio-economically disadvantaged (lowest
SEIFA quintile: 17.8 % versus 7.9 %, p < 0.01) and be ad-
mitted as a public patient (96.2 % versus 76.7 %, p < 0.01).
Models of care
The majority of super-obese women had a hospital-
based, medical model of care with few under the care of
midwives or private obstetricians, which was signifi-
cantly different from the comparison group (Table 2).
Changes in the model of care and rates of transfer be-
tween hospitals were higher for the super-obese group
compared with comparison women (Table 2). Fewer
than half (n = 173, 46.8 %) of the super-obese women
saw a dietician during pregnancy, while 70.5 % (n = 261)
consulted obstetric anaesthetists and 17.8 % (n = 66) con-
sulted maternal-fetal medicine specialists during pregnancy
(data unavailable for comparison group). Multi-disciplinary
meetings were held for 12 % of super-obese women during
the antenatal period to plan management.
Medical and obstetric complications during pregnancy
Super-obese women had significantly higher rates of ob-
stetric (42.0 % versus 23.2 %; AOR: 2.42, 95 % CI: 1.77–
3.29) and medical (33.3 % versus 13.0 %; AOR: 2.89,
95 % CI: 2.64–4.11) complications during pregnancy
(Table 3). Super-obese women were significantly more
likely to develop gestational diabetes (15.6 % versus
7.2 %; AOR: 2.52, 95 % CI: 1.58–4.65), pre-eclampsia(8.5 % versus 2.6 %; AOR: 3.43, 95 % CI: 1.72–6.84) or ges-
tational hypertension (12.3 % versus 1.5 %; AOR: 10.24,
95 % CI: 4.67–22.44) than comparison women. Of the 18
(4.9 %) of super-obese women who had antenatal throm-
boprophylaxis, nine (2.4 %) were given low-molecular
weight heparin.
Labour and birth
Compared to the comparison women, the super-obese
women were more likely to undergo induction of labour
or no labour (Table 4). The likelihood of having caesar-
ean section was significantly higher among super-obese
women (51.6 %) than the comparison women (31.7 %)
(AOR: 2.73, 95 % CI: 2.02–3.69) with 9.9 % of caesarean
section performed under general anaesthesia (Table 3).
The most common indications for planned caesarean
section were previous CS (72 %, n = 76), abnormal fetal
presentation (breech, transverse, or unstable lie (18 %,
n = 19), macrosomia (7 %, n = 7) and maternal medical
complications (7.5 %, n = 8). Shoulder dystocia oc-
curred in 11 (6 %) of super-obese women who gave
birth vaginally.
Perinatal outcomes
Birth outcomes were known for 365 (98.6 %) of the
super-obese women (n = 372 infants, including 7 sets of
twins. Super-obese women were significantly more likely
to give birth to babies with a birthweight ≥4 500 g
(AOR: 19.94, 95 % CI: 6.81–58.36) (Table 4). Thirty-six
(9.8 %) of 362 singleton infants born to super-obese
women had a birthweight ≥4 500 g, in contrast to 0.8 %
(n = 5/608) of the singleton infants in the comparison
group. Of the 36 singletons with a birthweight ≥4 500 g,
Table 1 Demographic and obstetric characteristics among
super-obese and comparison women who gave birth in
Australia, 2010
Super-obese group
(N = 370)
Comparison
(N = 621)
P value
No. % No. %
Age (years)
< 25 60 16.2 99 15.9 1.00
25–29 109 29.5 185 29.8
30–34 110 29.7 187 30.1
≥ 35 91 24.6 150 24.2
Indigenous status
No 341 92.2 572 92.1 0.23
Yes 17 4.6 19 3.1
Not stated 12 3.2 30 4.8
Marital status
Single 71 19.2 71 11.4 <0.01
Married/cohabit 277 74.9 508 81.8
Not stated 22 5.9 42 6.8
Private health insurance
No 356 96.2 474 76.3 <0.01
Yes 14 3.8 145 23.3
Not stated 0 0.0 2 0.3
Smoking during pregnancy
No 265 71.6 484 77.9 <0.01
Yes 88 23.8 100 16.1
Not stated 17 4.6 37 6.0
Assisted reproductive technology
No 357 96.5 574 92.4 0.17
Yes 11 3.0 29 4.7
Not stated 2 0.5 18 2.9
Parity
0 115 31.1 251 40.4 <0.01
1–2 173 46.8 313 50.4
3+ 82 22.2 57 9.2
Multiple gestation pregnancy
No 362 97.8 608 97.9 0.81
Yes 8 2.2 12 1.9
Not stated 0 0.0 1 0.2
Socio-economic statusa
Most disadvantage 1 66 17.8 49 7.9 <0.01
2 68 18.4 73 11.8
3 109 29.5 121 19.5
4 80 21.6 181 29.1
Least disadvantage 5 40 10.8 191 30.8
Not stated 7 1.9 6 1.0
Table 1 Demographic and obstetric characteristics among
super-obese and comparison women who gave birth in
Australia, 2010 (Continued)
Previous caesarean section (exclude primiparous)
No 140 54.9 250 67.6 <0.01
Yes 112 43.9 115 31.1
Not stated 3 1.2 5 1.4
aSocio-Economic Indexes for Areas Index for Relative Socio-economic Disadvantage
quintiles assigned to those residents in the most disadvantaged areas to Quintile 1
and those in the least disadvantaged areas to Quintile 5
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was no significant difference in preterm birth between
super-obese and comparison women (n = 39/370, 10.5 %
versus n = 57/621, 9.2 %) (Table 4). Of the singletons
born to super-obese women, 22.9 % (n = 83/362) were
admitted to the neonatal intensive care unit (NICU)
compared to 13.7 % (n = 83/608) of singletons in the
comparison group (Table 4). The perinatal mortality rate
for the infants born to super-obese women was 11.0 per
1 000 (95 % CI: 4.3–28.0) singleton births which con-
sisted of four stillbirths (one <30 weeks) and no neonatal
deaths. There were three stillbirths (2 antepartum and 1
intrapartum) among the infants born in the comparison
group (all <30 weeks) and one neonatal death, giving a
perinatal mortality rate of 6.6 per 1 000 (95 % CI: 2.6,
16.8) singleton births. Three of the four super-obeseTable 2 Model of care among super-obese and comparison
women who gave birth in Australia, 2010
Super-obese group
(N = 370)
Comparison
(N = 621)
P value
No. % No. %
Lead care provider
General practitioner 72 19.5 122 19.6 <0.01
Hospital medical 247 66.8 175 28.2
Hospital midwife 34 9.2 182 29.3
Private obstetrician 17 4.6 140 22.5
Not stated 0 0.0 2 0.3
Changed during pregnancy
No 312 84.3 566 91.1 <0.01
Yes 56 15.1 55 8.9
Not stated 2 0.5 0 0.0
Transfer
No 326 88.1 596 96.0 <0.01
Yes 44 11.9 25 4.0
Timing of maternal transfer
Antepartum 34 77.3 19 76.0 0.77
Intrapartum/Postpartum 9 20.5 6 24.0
Not stated 1 2.3 1 0.0
Table 3 Labour and birth characteristics among super-obese
and comparison women who gave birth in Australia, 2010
Super-obese group
(N = 370)
Comparison
(N = 621)
P value
No. % No. %
Multiple births
Singleton 362 97.8 608 97.9 0.81
Twin 8 2.2 12 1.9
Not stated 0 0.0 1 0.2
Labour
No 125 33.8 139 22.4 <0.01
Yes 241 65.1 482 77.6
Not stated 4 1.1 0 0.0
Induction of labour
No 100 41.5 351 72.8 <0.01
Yes 140 58.1 129 26.8
Not stated 1 0.4 2 0.4
Method of birth
Vaginal birth 176 47.6 424 68.3 <0.01
Caesarean section 191 51.6 197 31.7
Not stated 3 0.8 0 0.0
Caesarean section
Planned 103 53.9 122 61.9 0.1
Unplanned 87 45.5 73 37.1
Not stated 1 0.5 2 1.0
Use of general anaesthetic
No 172 90.1 191 97.0 0.01
Yes 19 9.9 6 3.0
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tension compared to none of the comparison women.
Postpartum maternal complications
Thirteen per cent (49/370) of the super-obese women ex-
perienced a postpartum infection; of those, 69 % (n = 34)
had undergone a caesarean section. The most common
infection was wound infection (n = 25, 51 %) with 12
(24 %) women having multiple complications from in-
fection. Postnatally, 224 (60.5 %) super-obese women
received thromboprophylaxis, of these, 78.1 % received
low-molecular-weight heparin (LMWH). Postnatal throm-
boprophylaxis was administered in 29.7 % of super-obese
women who gave birth vaginally compared to 90.5 % of
super-obese women following caesarean section (p < 0.01).
Of the 18 women who did not receive thrombopro-
phylaxis following caesarean section, two women were
aged >35 years, six continued to smoke during preg-
nancy and five had a history of hypertensive disorders
(HTD). The median length of stay for super-obese women
was 4 days (range 1–32 days). Super-obese women weresignificantly more likely to be admitted to a High Depend-
ency Unit (HDU) or Intensive Care Unit (ICU) (6.2 % ver-
sus 1.3 %; AOR: 5.67, 95 % CI: 2.31–13.93) compared to
the comparison women (Table 4). No maternal deaths
were woman reported in either group.
Discussion
Super-obesity was reported in more than 1 in 500
women giving birth in Australia with these women ex-
periencing higher rates of obstetric complications and
adverse perinatal outcomes. Compared to other women,
the birth experience of super-obese women was cha-
racterised by higher rates of caesarean section, general
anaesthesia, admission to HDU and ICU and hospital
transfer. Fewer than one in 10 super-obese women
accessed a midwifery led model of care or private obstet-
ric care with the usual model of care being a hospital-
based, medical model. Super-obese women had more
than twice the risk of caesarean section (CS) with almost
half of the CS unplanned and around 10 % conducted
under general anaesthesia. Maternal obesity may be an
independent risk factor for CS as it interferes with the
progress of labour, specifically the arrest of dilation in
active phase labour [13]. The higher rate of CS has been
explained in other studies by the association of super-
obesity with conditions such as gestational diabetes, ges-
tational hypertension and preeclampsia [14–16], all of
which were more prevalent in women in our study. This
is consistent with other research including comparison
with other obese women (BMI 30.0–49.9 kg/m2) [5].
Other studies of super-obese women (BMI ≥ 50 kg/m2)
have reported higher rates of both early preeclampsia
(AOR: 2.97, 95 % CI: 2.07- 4.26) and late preeclampsia
(AOR: 4.79, 95 % CI: 4.26–5.39) compared with normal
weight mothers (BMI = 18.5–24.9 kg/m2) [6]. While cli-
nicians have raised concerns about ability to monitor
progress of labour and assess fetal wellbeing in obese
women [17], it is argued that there is insufficient evi-
dence to justify a routine policy of CS for all super-obese
women solely because of higher recorded rates of com-
plications, but that the mode of birth should be based
on a careful assessment of risk factors [18]. Hospital
guidelines and other recommendations would suggest
thromboprophylaxis for women in the study group who
had caesarean sections is warranted. There is, however,
little or no differentiation of risk according to degree of
obesity [19–21]; although Martin et al. highlights the
dose–response of increased risk of thromboembolic
events and eclampsia as BMI increases and suggests this
can be usefully applied to other pregnancy-related com-
plications [16]. This amplified risk of morbidity accord-
ing to BMI is consistent with the Mbah study discussed
earlier and showed a significantly increased risk of pre-
eclampsia between super-obese women (BMI ≥ 50 kg/m2
Table 4 Maternal, obstetric and perinatal outcomes among super-obese and comparison women who gave birth in Australia, 2010a
Super-obese group Comparison OR AORb
(N = 370) (N = 621)
% %
Complications during pregnancy
Medical problems during pregnancy 33.3 13 3.35 (2.43–4.62) 2.89 (2.64–4.11)
Obstetric problems during pregnancy 42 23.2 2.40 (1.81–3.17) 2.42 (1.77–3.29)
Gestational diabetes 15.6 7.2 2.36 (1.56–3.59) 2.52 (1.58–4.65)
Gestational hypertension 12.3 1.5 9.33 (4.50–19.33) 10.24 (4.67–22.44)
Preeclampsia 8.5 2.6 3.42 (1.85–6.35) 3.43 (1.72–6.84)
Obstetric
Labour 65.8 77.6 0.55 (0.42–0.74) 0.49 (0.35–0.68)
Induction of labour 58.3 26.9 3.81 (2.75–5.28) 4.33 (3.21–6.24)
Caesarean section 52 31.7 2.33 (1.79–3.65) 2.73 (2.02–3.69)
Perinatal outcomes (singletons only)
Birthweight ≥4500 g 10.1 0.8 13.44 (5.22–34.57) 19.94 (6.81–58.36)
Admitted to NICU 23.7 13.9 1.93 (1.38–2.71) 1.83 (1.27–2.65)
Need for transfer 8.5 2.7 3.39 (1.82–6.31) 3.81 (1.93–7.55)
Preterm birth <37 weeks 10.1 8.1 1.28 (0.81–2.00) 1.18 (0.72,1.93)
Maternal outcomes
Admission to ICU 2.2 0.5 4.56 (1.25–17.32) 7.38 (1.52–35.87)
Admission to HDU 4.3 0.8 5.58 (2.43–15.37) 5.40 (1.78–16.38)
Admission to either ICU or HDU 6.2 1.3 5.09 (2.25–11.51) 5.67 (2.31–13.93)
OR odds ratio, AOR adjusted odds ratio, NICU neonatal intensive care unit, ICU intensive care unit, HDU high dependency unit
aTable 4 data excludes not stated and this may produce discrepant results to previous tables where not stated is included
bOutcomes are adjusted for age, Indigenous status, marital status, private health insurance, smoking during pregnancy, assisted reproductive technology, parity,
multiple gestation pregnancy, and Socio-Economic Indexes for Areas Index for Relative Socio-economic Disadvantage
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with Class III obesity (3.75 [3.59–3.92] [6].
The number of infants with birth weight > 4500 g
found in our cohort is similar to the UKOSS study of
super-obese women that reported a rate of almost nine
percent [7]. The long term clinical impact of a high
birthweight is unknown. While some studies [22] sug-
gest these infants may have higher rates of obesity and
metabolic syndrome in adolescence and adulthood,
whether this is a product of the intrauterine environ-
ment or of growing up in an environment where chil-
dren are exposed to sociodemographic factors that
promote the development of obesity is uncertain. There
were elevated rates of admission of infants to special and
intensive care units placing a higher burden on the
health system. A perinatal mortality rate of 11.0 per
1000 was not different to that in the comparison group
or to national Australian data [23] and was slightly lower
than that reported in the UKOSS study on super-obese
women (16.0 per 1000) [7]. There was no difference in
the rate of preterm birth among super-obese group, so
any difference in perinatal outcomes was not related to
prematurity.The rising prevalence of obesity in Australian women
of reproductive age suggests that strategies of weight loss,
diet, exercise and bariatric surgery have been of limited
benefit or that women are not aware of the potential
health adverse outcomes associated with obesity in preg-
nancy. Our study finds that 2.1 per 1000 women giving
birth in Australia are super-obese. The Royal Australia
and New Zealand College of Obstetricians and Gynaecol-
ogists (RANZCOG) recommends pre-conception man-
agement of obesity and weight loss through lifestyle
approaches of exercise and nutrition, bariatric surgery,
nutritional supplementation and psychosocial support. It
also recommends that women should have their BMI
measures at their first antenatal consultation and, if indi-
cated, multidisciplinary care should be organised to advise
and monitor about gestational weight gain, nutritional
supplementation, exercise and ensure access to antenatal
facilities with appropriate equipment [24].
The National Institute for Health and Clinical Excel-
lence has recommended bariatric surgery as a first-line
option for adults with BMI > 50 kg/m2, instead of lifestyle
interventions or drug treatment [25]. Studies have shown
that super-obese women who had bariatric surgery prior
Sullivan et al. BMC Pregnancy and Childbirth  (2015) 15:322 Page 8 of 10to pregnancy had lower rates of gestational hypertension,
pre-eclampsia, gestational diabetes, and macrosomic in-
fants compared with super-obese women who had not
had surgery [26–28]. Nutritional deficiencies during preg-
nancy have been reported among women following bariat-
ric surgery [29] and nutritional follow-up and careful
weight gain management should be provided. A recent
systematic review suggests that antenatal interventions
targeting diet and/or physical activity have mixed results
[30]. Some studies show a reduction in maternal weight
gain from antenatal dietary intervention but no effect on
maternal or infant morbidity. This may reflect the limita-
tion of intervention being focused on dietary advice alone
rather than a more holistic approach which provides sup-
port for the woman and her general wellbeing. There are
little data on interventions in super obese women. Inter-
ventions in the postnatal period should be considered to
encourage postpartum weight loss and improve outcomes
in subsequent pregnancies [31].
A strength of this study was the use of a comparison
group that was representative of the women giving birth
in Australia [23]. This allowed investigation of whether
there was an increased clinical impact and associated
burden on health services for women with super obesity.
Martin et al. [16] suggest the need for differential man-
agement of super-obese pregnant women compared to
the lower range of BMI 40–49.9 kg/m2, including the
need for larger antibiotic dosage for women with BMIs
of >50 kg/m2 to that of women with BMI of >35 kg/m2,
and a need for more research on the specific anticoagu-
lation requirements according to tiered classification of
obesity [5, 16]. A limitation of this approach is that it
potentially decreases the capacity to detect difference in
our study between the super-obese group and the com-
parison group in maternal and perinatal outcomes due
to the inclusion of obese women in the comparison
group.
A limitation of the study was that there was no specific
question on whether the super-obese women had previous
bariatric surgery. There was a question on previous
abdominal surgery with a free text response possible.
Interestingly, nine super-obese women and one control
reported gastric banding suggesting that any further re-
search on super-obese women should include questions
on bariatric surgery and laparoscopic-bands. Pre concep-
tion options for super-obese women may be the insertion
of an adjustable laparoscopic band or gastric sleeve pro-
cedure prior to pregnancy. These procedures are associ-
ated with fewer nutritional deficiencies than bariatric
surgery, and several observational studies have reported
encouraging results, including lower incidence of gesta-
tional diabetes, pregnancy induced hypertension and lower
weight gain during pregnancy. However women with ad-
justable laparoscopic bands require close monitoring froma multidisciplinary team and may need the band adjusted
during pregnancy, especially in women with frequent
vomiting [32]. Adjustable laparoscopic band surgery and
or gastric sleeves are rarely available in the public or Medi-
care funded hospital system in Australia. In our sample of
super obese women, only 3.8 % had private health insur-
ance, and over one third were from the two least advan-
taged quintiles of socio-economic status, suggesting that
lap band surgery pre-pregnancy may not be an option for
many women.
Measurement error of BMI is another potential limita-
tion of the study. Despite recommendations for maternal
BMI to be recorded at the booking visit [24, 33] this was
not done at all participating AMOSS sites nor were ser-
ial measures of BMI throughout pregnancy available. In
a separate survey to participating sites in 2010, BMI at
booking was routinely undertaken at 74 % of the 195
sites that responded. There may be some information
bias regarding the BMI as weight and/or height could be
self-reported or measured depending upon the maternity
unit practice. At this level of obesity, some error in the
BMI precision is likely to have minimal impact on the
generalisability of the results, as alternative measures
such as skinfolds are impractical and unreliable in gen-
eral clinical practice.
A potential limitation of the study was the incremental
participation of maternity sites in AMOSS over the
course of the study which may have impacted recruit-
ment of cases. Conversely, a strength of the study is that
the findings are consistent with routine perinatal data
which also demonstrates variation in the prevalence of
super-obesity across jurisdictions ranging from 1.8 per
1000 births in NSW [34] to 3.67 per 1000 in Queensland
[35] and 4.68 per 1000 births in Western Australia [36].
A second strength was the distribution of participating
sites which was representative of Australian maternity
services [37].
The increasing prevalence of super-obesity has import-
ant implications for maternity services as the evidence
suggests current strategies have had limited impact.
Super-obesity is associated with and may be a manifest-
ation of complex socio-economic disadvantage and needs
innovative interventions and strategies to address under-
lying health inequity. This study found over a third of
super-obese women were in the two most disadvantaged
quintiles with only 10.8 % in the least disadvantaged and
confirms previous research findings of lower socio-
economic status being associated with super-obesity
[38–41]. Super obese women risk substantial co-
morbidity affecting both them and their offspring. This
calls for targeted strategies to address weight gain be-
fore, within and between pregnancies, that are appropri-
ate, collaborative and provide training for clinicians
within the health services. In the absence of effective
Sullivan et al. BMC Pregnancy and Childbirth  (2015) 15:322 Page 9 of 10interventions to enable women to lose weight (or maintain
weight) during pregnancy, super-obese women planning a
pregnancy should be supported to make lifestyle changes
or consider laparoscopic band, gastric sleeve or bariatric
surgery prior to pregnancy.
Conclusions
The findings from our study underline the imperative to
prioritise initiatives that address the increased perinatal
risks of super-obese women and their babies. The overall
resource burden of maternity care for super-obese women
was evident with higher rates of obstetric and medical
complications, intervention in pregnancy and childbirth,
and for infants postnatally. Super-obesity in pregnancy is
associated with social disadvantage. There is an urgent
need to address pre-pregnancy and pregnancy care and
ensure that appropriate initiatives are in place to reduce
associated inequalities in perinatal outcomes and future
pregnancies of super-obese women.
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